The SU.VI.MAX study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

Archives of Internal Medicine

Volumn 164, Issue 21, 2004, Pages 2335-2342

  Hercberg, Serge ^a,b   Galan, Pilar ^a   Preziosi, Paul ^a   Bertrais, Sandrine ^a   Mennen, Louise ^a,b   Malvy, Denis ^c   Roussel, Anne Marie ^d   Favier, Alain ^d   Briançon, Serge ^e  

^a INSERM   (France)

^b Bioinformatique et Chimie Moléculaire   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; MINERAL; PLACEBO; SELENIUM; VITAMIN; ZINC;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CARCINOMA IN SITU; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

EID: 1842574410     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.21.2335     Document Type: Article

References (35)

1. Ames BN. Dietary carcinogens and anticarcinogens. Science. 1983;221:1256-1264.
2. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med. 1994;97:5S-13S.
3. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53:189S-193S.
4. Byers T, Perry G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr. 1992;12:139-159.
5. Steinmeitz KA, Potter JD. Vegetables, fruit and cancer prevention: a review. J Am Diet Assoc. 1996;96:1027-1039.
6. Stampfer MJ, Rimm B. Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. Am J Clin Nutr. 1995;62:1365S-1369S.
7. Kohlmeier L, Hastings SB. Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr. 1995;62:1370S-1376S.
8. Stampfer MJ, Rimm B. A review of the epidemiology of dietary antioxidants and risk of coronary heart disease. Can J Cardiol. 1993;19:14B-18B.
9. Biot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993; 85:1483-1492.
10. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
11. Omenn GS, Goodman GE, Thorquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
12. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
13. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst. 1999;91:2102-2106.
14. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33.
15. Hercberg S, Galan P, Preziosi P, et al. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Int J Vitam Nutr Res. 1998;68:3-20.
16. Hercberg S, Preziosi P, Briançon S, et al. A primary prevention trial of nutritional doses of antioxidant vitamins and minerals on cardiovascular diseases and cancers in general population: The SU.VI.MAX Study. Control Clin Trials. 1998;19:336-351.
17. Bourgeois CF, Chartois RR, Counstans MF, George PR. Automated determination of vitamin C in foodstuffs and biological tissues. Analysis. 1989;9:519-525.
18. Vuilleumier JP, Keller HE, Gysel D, Hunziker F. Clinical chemical methods for the routine assessment of the vitamin status in human population, I: the fat-soluble vitamins A and E and beta-carotene. Int J Vitam Nutr Res. 1983;53:265-272.
19. Arnaud J, Bellanger J, Bienvenu F, Chappuis P, Favier A. Méthode recommandée de dosage du zinc sérique par absorption atomique en flamme. Ann Biol Clin (Paris). 1986;44:77-87.
20. Nève J, Chamart S, Molle L. Optimisation of a direct procedure of selenium in plasma and erythrocyte using Zeeman effect atomic absorption spectrometry. In: Bratter P, Schamer P, eds. Trace Element Analytical Chemistry in Medicine and Biology. Berlin, Germany: Walter de Gruyter; 1987;4:1-10.
21. Burton GW, Ingold KU. β-carotene: an usual type of lipid antioxidant. Science. 1984;224:569-573.
22. Palozza P, Caviello G, Bartoli GM. Prooxidant activity of beta-carotene under 100% oxygen pressure in rat liver microsomes. Free Radic Biol Med. 1995;19:887-892.
23. Hercberg S, Preziosi P, Galan P, et al. Vitamin status of a healthy French population: dietary intakes and biochemical markers. Int J Vitam Nutr Res. 1994;64:220-232.
24. De Waart FG, Scheuten EG, Stalenhoef AFH, Kok FJ. Serum carotenoids, α-tocopherol and mortality risk in a prospective study among Dutch elderly. Int J Epidemiol. 2001;30:136-143.
25. Wallstrom P, Wirfalt E, Lahmann PH, Gullberg B, Janzon L, Berglund G. Serum concentration of β-carotene and α-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr. 2001;73:777-785.
26. Curran-Celentano J, Hammond BR, Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of luthein and zeaxanthin in adults in Midwest population. Am J Clin Nutr. 2001;74:796-802.
27. Olmedilla B, Granado F, Southon S, et al. A European multicentre, placebo-controlled supplementation study with α-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Clin Sci. 2002;102:447-456.
28. Van Poppel G, Goldbohm RA. Epidemiologic evidence for β-carotene and cancer prevention. Am J Clin Nutr. 1995;62:1393S-1402S.
29. Ziegler RG. Vegetables, fruit, and carotenoids, and the risk of cancer. Am J Clin Nutr. 1991;53:251s-259s.
30. Trial GP. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione Trial. Lancet. 1999;354:447-455.
31. Heart Outcomes Prevention Evaluation Study Investigators. Effect of Ramipril on cardiovascular outcomes in people with diabetes mellitus: results of the HOPE study and micro HOPE study. Lancet. 2000;355:253-259.
32. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017-2023.
33. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-1592.
34. Stephens MG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786.
35. Drewnowski A, Rock CL, Henderson SA, et al. Serum beta-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. Am J Clin Nutr. 1997;65:1796-1802.